https://www.selleckchem.com/pr....oducts/irak4-in-4.ht
Aims/introduction There is uncertainty about the direct medical costs of type 2 diabetes mellitus (T2DM) patients with cancers. Materials and methods A population-based retrospective cohort of 99915 T2DM patients from Hong Kong Hospital Authority between 2006 and 2017 was assembled. 16869 patients who had initial cancer diagnosis after T2DM were matched with 83046 patients without cancer (controls) using a matching ratio up to one-to-five propensity score-matching method. Patients were divided into four categories according to life e
Like
Comment
Share
